Blogg

7.9.25 | Policy

SWHR Sends Letter to Congress Calling to Preserve Women’s Health Research Funding

6.9.25 | Policy

SWHR Sends Comments to OPM on Proposed Rule Regarding Civil Service

5.29.25 | Policy

SWHR Sends Letter to CMS Administrator Requesting Reconsideration of Contract Year 2026 Medicare Advantage and Part D Proposed Rule Provisions

5.12.25 | Policy

SWHR Leads Women’s Health Stakeholders on Letter to Senate Appropriations Committee

4.17.25 | Policy

SWHR Submits Outside Witness Testimony on FY 2026 Appropriations

4.10.25 | Policy

SWHR Provides Comments on Center for Innovation & Value Research’s Draft “A Blueprint for Patient-Centered Value Research”

4.7.25 | Policy

SWHR Sends Letter to FDA in Study of Sex Differences in the Clinical Evaluation of Medical Products

1.27.25 | Policy

SWHR Sends Letter to Centers for Medicare & Medicaid Services on the Contract Year 2026 Medicare Advantage and Part D Proposed Rule

1.8.25 | Policy

SWHR Sends Letter Supporting Expanded Access to Anti-obesity Medications Under Medicare Part D

12.6.24 | Policy

SWHR Sends Letter Responding to FDA Draft Guidance on Incorporating Voluntary Patient Preference Information